Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23105144 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Pegylated Interferon-alpha 2a, 180 mcg/week sc;   Drug: Pegylated Interferon-alpha 2a, 90 mcg/week sc
2 Recruiting A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
Condition: HIV
Intervention: Biological: AGS-004

Indicates status has not been verified in more than two years